Exact Sciences (EXAS) Capital Expenditures (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Capital Expenditures data on file, last reported at $31.2 million in Q4 2025.

• Capital Expenditures for Q4 2025 came in at $31.2 million, up 157.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $134.7 million (up 199.24% YoY), and the FY2025 annual result was $134.7 million, up 199.24% from the prior year.
• Capital Expenditures climbed to $31.2 million in Q4 2025 per EXAS's latest filing, from $29.9 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $72.9 million in Q4 2022 and troughed at -$88.8 million in Q4 2023.
• A 5-year average of $22.6 million and a median of $31.2 million in 2025 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 498.21% in 2022, then sank 221.81% in 2023.
• A 5-year view of Capital Expenditures shows it stood at -$18.3 million in 2021, then surged by 498.21% to $72.9 million in 2022, then slumped by 221.81% to -$88.8 million in 2023, then surged by 38.41% to -$54.7 million in 2024, then surged by 157.15% to $31.2 million in 2025.
• Business Quant data shows EXAS's Capital Expenditures at $31.2 million in Q4 2025, $29.9 million in Q3 2025, and $42.3 million in Q2 2025.